Jim Catto
LightNews LightNews
banner
jimcatto.bsky.social
Jim Catto
@jimcatto.bsky.social
520 followers 140 following 68 posts
Father & husband. Urological surgeon. Sheffield Hospitals. NIHR Research Professor. He/Him. Views my own
Posts Replies Media Videos
Reposted by Jim Catto
bursturology.bsky.social
🚀 Exciting announcement!

⭐️ Join us at #BAUS25 for our special session on Monday, 16 June!

🕓 16:30 - 16:45
📍 Charter 3

📢 We are thrilled to welcome our keynote speaker, Freddie Hamdy, who will discuss, "The Challenge of Misinformation"!

#BURSTatBAUS #UroSoMe @bausurology.bsky.social
May 28, 2025 at 6:31 AM
Reposted by Jim Catto
sophiaanderton.bsky.social
An important (very short) film from Steve McQueen - don’t be embarrassed to talk about #ProstateCancer. Can effect all men but there’s a higher risk for black men.

www.embarrassedfilm.org

It’ll take less than 2 mins of your time to watch.
An inspiring talk at #BAUS25
www.embarrassedfilm.org | A SIR STEVE MCQUEEN FILM Raising awareness of prostate cancer within the black community
www.embarrassedfilm.org
June 16, 2025 at 10:35 AM
Reposted by Jim Catto
londonprostate1.bsky.social
Inaccuracy of rapid at home PSA tests

www.bbc.co.uk/news/article...
Prostate cancer: Rapid at-home PSA tests spark concerns
Testing for PSA protein can indicate whether a man is at risk of prostate cancer.
www.bbc.co.uk
March 5, 2025 at 9:01 AM
Reposted by Jim Catto
drrachelhubbard.bsky.social
Woohoo! Great work team

@jimcatto.bsky.social

bmjopen.bmj.com/content/bmjo...
bmjopen.bmj.com
February 11, 2025 at 6:34 PM
jimcatto.bsky.social
www.sheffield.ac.uk/news/thousan...
Thousands of men in Yorkshire to take part in new prostate screening trial
​​​​​​​Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial led by the University of Sheffield.
www.sheffield.ac.uk
February 4, 2025 at 10:10 AM
jimcatto.bsky.social
www.yorkshirecancerresearch.org.uk/news/thousan...
Thousands of men in Yorkshire to take part in new prostate screening trial - Yorkshire Cancer Research
Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial funded by Yorkshire Cancer Research.
www.yorkshirecancerresearch.org.uk
February 4, 2025 at 9:47 AM
Reposted by Jim Catto
ip-london.bsky.social
🏃 Flying start to #IP9ATLAS - first 5️⃣0️⃣ patients recruited!

🔎 Comparing regular MRI scans to standard of care in patients with prostate cancer on active surveillance

🎉 Thank you to our site teams Imperial College Healthcare NHST, Dartford and Gravesham NHST & Frimley Health NHSFT
January 15, 2025 at 1:46 PM
Reposted by Jim Catto
yukselurun.bsky.social
Can mpMRI replace TURBT for faster treatment in MIBC?
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social
ascopubs.org/doi/10.1200/JC…
January 15, 2025 at 8:25 PM
jimcatto.bsky.social
Great to see this finally out #bladdercancer

ascopubs.org/doi/10.1200/...
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial
PURPOSETransurethral resection of bladder tumor (TURBT) is the initial staging procedure for new bladder cancers (BCs). For muscle-invasive bladder cancers (MIBCs), TURBT may delay definitive treatmen...
ascopubs.org
January 15, 2025 at 9:01 AM
Reposted by Jim Catto
brookmans76.bsky.social
Now published: This MA is the basis for our ongoing #ZMoveMent1 study evaluating the impact of endurance*resistance training on QoL, oncological outcomes, fitness in #ProstateCancee pts
👉 we still don’t use #PhysicalExercise in cancer pts in an optimal way
👉 www.mdpi.com/2072-6694/16...
January 15, 2025 at 8:09 AM
jimcatto.bsky.social
www.sheffield.ac.uk/news/surviva...
Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery
​​​​​​​A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to b...
www.sheffield.ac.uk
January 13, 2025 at 11:02 AM
Reposted by Jim Catto
oncodaily.bsky.social
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer

oncodaily.com/insight/sasa...

#BladderCancer #Cancer #EventFreeSurvival #EFS #OncoDaily #Oncology #Pfizer #Sasanlimab
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer - OncoDaily
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer / bladder cancer, cancer, event-free survival (EFS), Neal Shore,
oncodaily.com
January 12, 2025 at 4:43 PM
Reposted by Jim Catto
brookmans76.bsky.social
#CREST trial with positive results for #PD-1 in HR #NMIBC!
✅The study evaluated #sasanlimab (PD-1i)+BCG vs standard #BCG (induction + maintenance) in BCG-naïve, HR NMIBC.
✅The study met its primary endpoint with significant improvement of EFS
pfizer.com/news/press-rel…
@oncodaily.bsky.social
https://pfizer.com/news/press-rel…
January 11, 2025 at 8:59 AM
Reposted by Jim Catto
npca-natcan.bsky.social
Key findings include an increase in men newly diagnosed with prostate cancer: in 2023 in England, a 9% increase when compared to 2022 and a 25% increase compared to 2019. In 2022 in Wales, a 26% increase compared to 2021.
January 9, 2025 at 10:15 AM
jimcatto.bsky.social
Geographic patterns of #prostatecancer reflect awareness, mens health and PSA testing. Big differences exist in the UK and other countries @prostatecanceruk.bsky.social

prostatecanceruk.org/about-us/new...
Huge North-South divide in prostate cancer diagnoses
We want to stop prostate cancer being a killer. We fund groundbreaking research, drive improvements in treatment, and fight injustice in care.
prostatecanceruk.org
January 10, 2025 at 12:31 PM
jimcatto.bsky.social
Credit the authors ... its hard to find defendants of TRUS-Bx in an era of TREXIT. RCTs mostly show equivalence but fewer infections - see www.bmj.com/content/387/... There is loss of equipoise amongst urologists. Patient views under-represented.

www.eu-focus.europeanurology.com/article/S240...
DEFINE_ME
www.eu-focus.europeanurology.com
January 10, 2025 at 8:49 AM
jimcatto.bsky.social
(Over)diagnosis of very low risk #prostatecancer in the USA. The disease that won't go away ..... despite MRI use. Time to abandon random biopsy @dr-coops.bsky.social

euoncology.europeanurology.com/article/S258...
DEFINE_ME
euoncology.europeanurology.com
January 10, 2025 at 8:38 AM
jimcatto.bsky.social
Nice. How to write a Response to reviewers. Amazing how many authors ignore simple questions. Reviewers are usually helping you improve your work.
Well done @vickersbiostats.bsky.social @euplatinum.bsky.social

www.europeanurology.com/article/S030...
DEFINE_ME
www.europeanurology.com
January 10, 2025 at 8:34 AM
jimcatto.bsky.social
1. HIFU vs Radical prostatectomy non-randomised comparison. Large 1,967 HIFU & 1,361 RP, contemporary 2015-19. 62% intermediate-risk PC. Similar adverse events except long term continence and erectile scores. Less salvage treatments with HIFU.

www.europeanurology.com/article/S030...
DEFINE_ME
www.europeanurology.com
January 10, 2025 at 8:29 AM
Reposted by Jim Catto
drelliedavison.bsky.social
I’ve just signed the @prostatecanceruk.bsky.social letter to the Secretary of State for Health and Social Care @rthonwesstreeting.bsky.social asking for simple and free changes to outdated #prostatecancer testing guidelines.

Add your name now - it takes less than a minute!
Men are being left behind by outdated prostate cancer guidelines.
I’ve just signed Prostate Cancer UK’s letter to the Secretary of State for Health and Social Care so that we can improve the outcomes and experience for men in the UK with prostate cancer. Add your n...
campaigns.prostatecanceruk.org
January 9, 2025 at 9:56 AM
Reposted by Jim Catto
jlvasquez82.bsky.social
Moving from the dance floor 🕺💃 to the balcony 🏛️” - Great leadership requires both action & reflection. Insightful session by @brookmans76.bsky.social at #EAUTalentIncubator on finding balance in leadership! 👏✨ @uroweb.bsky.social #LeadershipDevelopment
January 9, 2025 at 11:08 AM
Reposted by Jim Catto
npca-natcan.bsky.social
The National Prostate Cancer Audit State of the Nation Report 2024 has been published! It is available here www.npca.org.uk/reports/npca... alongside its appendix, methodology supplement and data tables.
NPCA State of the Nation Report 2024 - National Prostate Cancer Audit
The aim of the National Prostate Cancer Audit (NPCA) is to evaluate the patterns of care and outcomes for patients with prostate cancer in England and Wales, and to support services to improve the qua...
www.npca.org.uk
January 9, 2025 at 10:15 AM
Reposted by Jim Catto
erictopol.bsky.social
In over 460,000 women throughout Germany, #AI second readings of mammograms led to improved breast cancer detection, a lower recall rate, and significantly reduced workload
nature.com/articles/s41... open-access
January 7, 2025 at 2:30 PM
Reposted by Jim Catto
erictopol.bsky.social
Mosaic pattern loss of Y chromosome, which occurs in ~40% of men by age 70, is causally linked to heightened risk of many diseases, including cardiovascular, bladder cancer, and Alzheimer's. But it's almost never assessed clinically.
A new review
nature.com/articles/s41...
January 5, 2025 at 6:34 PM
Reposted by Jim Catto
erictopol.bsky.social
Bonus effect. When a drug for diabetes significantly reduces kidney stones, results of a randomized trial of empagliflozin (Jardiance), a SGLT-2 inhibitor, in people without diabetes
www.nature.com/articles/s41...
January 2, 2025 at 6:05 PM